3Yen YH, Changchien CS, Wang JH, et al. A modified ~M- based Japan Integrated Score combined with AFP level may serve as a better staging system for early-stage predominant hepateeelluIar carcinoma patients [J]. Dig Liver Dis, 2009,41 (6) :431-441.
8Farinati F, Rinaldi M, Gianni S, et al. How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic system [ J ]. Cancer,2000, 89 ( 11 ) :2266 - 2273.
9The Cancer of the Liver Italian Program ( CLIP ) investigators. Prospective validation of the CLIP score : A new prognostic system for patients with cirrhosis and hepatocellular carcinoma[ J]. Hepatology, 2000, 31 (4) : 840 - 845.
10Leung WT, Tang MY, Zee B, et al. Construction of the Chinese university prognostic index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the cancer of the Italian program staging system: a study based on 926 patients [J]. Cancer, 2002, 94 (6) : 1760 - 1769.
4Qinghua Meng,Zhengqiang Yang,Zhenyu Zhu,Juan Li,Xinyu Bi,Xiao Chen,Chunyi Hao,Zhen Huang,Fei Li,Xiao Li,Guangming Li,Yinmo Yang,Yefan Zhang,Haitao Zhao,Hong Zhao,Xu Zhu,Jiye Zhu,Jianqiang Cai,The Liver Tumor Branch of the China International Exchange and Promotive Association for Medical and Healthcare(CPAM),The Gastrointestinal Cancer Multidisciplinary Cooperation Group of Cancer Hospital,Chinese Academy of Medical Sciences&Peking Union Medical College,The Liver Cancer Professional Committee of Chinese Medical Doctor Association.Chinese expert consensus on the overall management of liver function in conversion therapy for liver cancer(2022 edition)[J].Chinese Medical Journal,2023,136(24):2909-2911.
